Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Registration opens for RNAi and High Content Imaging 2011

Published: Tuesday, February 08, 2011
Last Updated: Tuesday, February 08, 2011
Bookmark and Share
Molecular Devices Inc. announces that they have opened registration for its RNAi & High Content Imaging Symposium 2011, to be held at the Oxford Spires Four Pillars, Oxford on 1st April 2011.

The meeting has been structured to reflect the significant role that RNAi and High Content Imaging has in the market and to address these areas we are bringing together the leading experts in industry and academia to explore the cutting edge of new therapeutics being researched and brought to the marketplace.

“Molecular Devices’ imaging symposium is growing in stature each year as a major highlight in the imaging research calendar”, explains Richard Patterson, European Drug Discovery Director. “Visitors appreciate the unique opportunity this symposium provides to meet and network with researchers in a comfortable environment that is conducive to learning about new applications in High Content Screening.”

Join influential and respected scientists to discuss the expansion of RNAi profiling techniques and how to enhance gene expression assays using high content imaging systems. The preliminary agenda includes presentations by:

•    Session Chair: Dr. Anthony Davies, Trinity College Dublin
•    Dr. Peter Horvath, Light Microscopy Centre, ETH Zurich
•    Dr. Stephen Brown, University of Sheffield
•    Dr. Olivier Pardo, Imperial College London
•    Dr. Karol Kozak, LMC-RISC, Institute for Biochemistry, ETH Zurich
•    Dr. Christoph Kasper and Dr. Mario Emmenlauer, Biozentrum Basel
•    Dr. Ross Paveley, London School Of Hygiene Tropical Medicine,
•    Dr. Ami Ketley, University of Nottingham
•    Dr. Miguel Mano, iRNA HTS Screening facility, International Centre for Genetic Engineering and Biotechnology (ICGEB)

Additional user-presentations will focus on RNAi profiling techniques, tips and tricks for interrogating large-scale RNAi libraries as well as automated data analysis and integration. Do not miss this opportunity to join your industry colleagues…

Registration for this event is free of charge. Attendance will be limited, so please register early for this event at http://imagingsymposium2011.eventbrite.com, a new dedicated web site focused exclusively on Molecular Devices symposiums.

Refreshments and a buffet lunch will be served during the symposium.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors
The new Board will support the Company’s strategic focus on the discovery, development, and commercialization of radiopharmaceuticals for molecular imaging and targeted radiotherapy of prostate cancer.
Wednesday, February 29, 2012
Molecular Devices’ RNAi and High Content Imaging Symposium
The RNAi and High Content Imaging Symposium will be discussed at a one day symposium to be held at The Burlington Hotel, Dublin, Ireland, September 16, 2010. The symposium follows the RNAi & miRNA Europe Conference.
Tuesday, September 14, 2010
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!